News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: iwfal post# 161042

Tuesday, 07/16/2013 6:28:04 PM

Tuesday, July 16, 2013 6:28:04 PM

Post# of 257257
OPLI* is another (early) XOMA competitor in NIU:

http://finance.yahoo.com/news/ophthalix-initiate-phase-ii-study-214400692.html

*An 83%-owned subsidiary of Israel’s Can-Fite BioPharma.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now